- Report
- April 2025
- 175 Pages
Global
From €3970EUR$4,490USD£3,425GBP
- Report
- May 2025
- 230 Pages
United States
From €2476EUR$2,800USD£2,136GBP
€3537EUR$4,000USD£3,051GBP
Vaqta is a vaccine developed by Merck & Co. Inc. It is used to prevent hepatitis A, a viral infection that can cause serious liver damage. The vaccine is administered as a single dose and is approved for use in adults and children over the age of one. It is available in both injectable and oral forms.
The Vaqta market is composed of a variety of companies that produce and distribute the vaccine. These companies include Merck & Co. Inc., Sanofi Pasteur, GlaxoSmithKline, Pfizer, and Novartis. These companies are responsible for the production, distribution, and marketing of the vaccine. They also provide support and education to healthcare providers and patients about the vaccine. Additionally, they are involved in research and development of new vaccines and treatments for hepatitis A. Show Less Read more